The effect of gender in clinically isolated syndrome (CIS): a meta-analysis (Q37945048)

25 August 2017

0 references

The effect of gender in clinically isolated syndrome (CIS): a meta-analysis (English)

1 reference

clinically isolated syndrome

25 August 2017

main subject

1 reference

3

Gavin Giovannoni

1 reference

25 August 2017

Ruth Dobson

1

1 reference

25 August 2017

Sreeram Ramagopalan

series ordinal

2

1 reference

25 August 2017

publication date

12 October 2011

1 reference

Multiple Sclerosis Journal

25 August 2017

published in

1 reference

25 August 2017

volume

18

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

600-604

1 reference

European Charcot Foundation Lecture: the natural history of multiple sclerosis and gender

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Environmental factors and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Clinically isolated syndromes: predicting and delaying multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

MRI only conversion to multiple sclerosis following a clinically isolated syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Clinical isolated syndrome: a 3-year follow-up study in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Brainstem lesions in clinically isolated syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Latitudinal variation in incidence and type of first central nervous system demyelinating events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis according to baseline MRI findings: comparison of revised McDonald criteria and Swanton modified criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Clinical predictors of early second event in patients with clinically isolated syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Optical coherence tomography in clinically isolated syndrome: no evidence of subclinical retinal axonal loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Clinically isolated acute transverse myelitis: prognostic features and incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Smoking is a risk factor for early conversion to clinically definite multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Is optic neuritis more benign than other first attacks in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Acute optic neuritis: a prospective study of risk factors for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

The changing demographic pattern of multiple sclerosis epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Sex ratio of multiple sclerosis in Canada: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

Cigarette smoking and risk of MS in multiplex families

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

A three-year, multi-parametric MRI study in patients at presentation with CIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511426740

21 January 2018

Identifiers

DOI

10.1177/1352458511426740

1 reference

25 August 2017

1 reference